Cuu Long Pharmaceutical JSC
VN:DCL
Cash Flow Statement
Cash Flow Statement
Cuu Long Pharmaceutical JSC
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
110 284
|
111 912
|
103 717
|
119 554
|
141 542
|
143 301
|
132 709
|
96 643
|
78 122
|
87 673
|
80 935
|
68 777
|
74 898
|
73 236
|
|
| Depreciation & Amortization |
34 273
|
36 602
|
38 582
|
38 614
|
38 135
|
37 946
|
37 848
|
37 801
|
38 278
|
38 432
|
38 338
|
38 258
|
40 807
|
54 517
|
|
| Other Non-Cash Items |
(16 919)
|
(13 628)
|
(13 375)
|
(12 484)
|
15 010
|
20 752
|
30 611
|
41 604
|
24 074
|
23 913
|
24 882
|
22 846
|
27 406
|
41 430
|
|
| Cash Taxes Paid |
33 440
|
21 195
|
20 969
|
20 969
|
25 261
|
32 138
|
32 152
|
32 156
|
12 576
|
14 926
|
14 964
|
14 964
|
13 164
|
13 164
|
|
| Cash Interest Paid |
33 237
|
34 819
|
37 929
|
36 358
|
35 991
|
34 201
|
33 513
|
31 542
|
29 199
|
28 656
|
26 253
|
25 437
|
28 592
|
42 041
|
|
| Change in Working Capital |
(89 579)
|
(268 473)
|
(149 970)
|
(297 961)
|
(644 757)
|
(459 496)
|
(445 303)
|
(442 530)
|
(117 932)
|
(146 765)
|
(154 412)
|
(60 068)
|
(104 454)
|
(185 691)
|
|
| Cash from Operating Activities |
38 059
N/A
|
(133 588)
N/A
|
(21 046)
+84%
|
(152 277)
-624%
|
(450 071)
-196%
|
(257 498)
+43%
|
(244 135)
+5%
|
(266 482)
-9%
|
22 530
N/A
|
3 242
-86%
|
(10 268)
N/A
|
69 813
N/A
|
38 658
-45%
|
(16 508)
N/A
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(152 612)
|
(70 126)
|
(52 062)
|
(158 805)
|
(233 028)
|
(275 115)
|
(332 659)
|
(233 145)
|
(222 874)
|
(243 861)
|
(231 466)
|
(172 850)
|
(102 942)
|
(117 802)
|
|
| Other Items |
368 383
|
154 594
|
74 697
|
(149 959)
|
326 205
|
435 765
|
480 685
|
479 699
|
53 868
|
39 626
|
(2 931)
|
6 467
|
(2 086)
|
(21 432)
|
|
| Cash from Investing Activities |
215 771
N/A
|
84 468
-61%
|
22 634
-73%
|
(308 764)
N/A
|
93 177
N/A
|
160 650
+72%
|
148 026
-8%
|
246 554
+67%
|
(169 006)
N/A
|
(204 235)
-21%
|
(234 397)
-15%
|
(166 382)
+29%
|
(105 028)
+37%
|
(139 234)
-33%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
20 000
|
375 205
|
375 205
|
355 205
|
355 205
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(274 447)
|
(310 677)
|
(289 294)
|
218 153
|
13 295
|
56 380
|
(10 182)
|
(77 079)
|
117 138
|
196 762
|
231 170
|
124 113
|
63 320
|
146 516
|
|
| Cash from Financing Activities |
(254 447)
N/A
|
64 528
N/A
|
85 911
+33%
|
573 358
+567%
|
368 500
-36%
|
56 380
-85%
|
(10 182)
N/A
|
(77 079)
-657%
|
117 138
N/A
|
196 762
+68%
|
231 170
+17%
|
124 113
-46%
|
63 320
-49%
|
146 516
+131%
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
(6)
|
(7)
|
5
|
1
|
(9)
|
(6)
|
(17)
|
(16)
|
3
|
23
|
(9)
|
8
|
(12)
|
(8)
|
|
| Net Change in Cash |
(623)
N/A
|
15 401
N/A
|
87 505
+468%
|
112 318
+28%
|
11 596
-90%
|
(40 475)
N/A
|
(106 307)
-163%
|
(97 024)
+9%
|
(29 335)
+70%
|
(4 209)
+86%
|
(13 503)
-221%
|
27 552
N/A
|
(3 063)
N/A
|
(9 234)
-201%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(114 553)
N/A
|
(203 714)
-78%
|
(73 108)
+64%
|
(311 082)
-326%
|
(683 099)
-120%
|
(532 613)
+22%
|
(576 794)
-8%
|
(499 627)
+13%
|
(200 343)
+60%
|
(240 620)
-20%
|
(241 734)
0%
|
(103 037)
+57%
|
(64 285)
+38%
|
(134 311)
-109%
|
|